GSK's latecomer to the PD-1/PD-L1 inhibitor category Jemperli has barely started to bring in revenues, and is a world away from the company's hopes of blockbuster revenues by 2031.

We may see a few isolated showers or thunderstorms this week. Here's a look at your FOX 5 Storm Team forecast. We're off to a mostly dry start to the work week, with larger storm chances in tow ...

FOX 9’s Bill Keller has more on the story. FOX 9 is learning more about two of the victims from Tuesday night’s shooting at East 25th Street near Bloomington Avenue. It's where three people ...